foxo4-dri peptide senolytic Frontiers FOXO4-DRI: Human Trial Status, Cancer

Comprehensive blood work allows our providers to assess hormone levels, metabolic function, and overall health before recommending any treatment

Its utility shines brightest in studies specifically centered on reducing adipose tissue and improving body composition

It is commercially available now, prescribed by physicians, and covered by an increasing number of insurance plans

Side effects that occur less frequently are lightheadedness, nausea, fatigue, headache, dizziness, warmth, or flushing

Patient-reported sleep quality tools (PSQI, ISI) are commonly used alongside objective markers

By preventing nicotinamide methylation, the compound increases intracellular NAD+ availability, which in turn activates sirtuins and other NAD+-dependent enzymes critical for metabolic homeostasis